Home › Prostate Cancer › Virginia
Prostate Cancer clinical trials in Virginia
53 studies for Prostate Cancer are looking for participants at sites in Virginia.
Cities in Virginia
- Richmond19 studies
- Arlington17 studies
- Charlottesville15 studies
- Norfolk8 studies
- Roanoke6 studies
- Virginia Beach3 studies
- Alexandria3 studies
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- University of Virginia Cancer Center, Charlottesville
- VCU Massey Comprehensive Cancer Center, Richmond
RecruitingPhase 3
Ages 18 and older · Men · Updated Nov 13, 2026 · NCT04423211Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Virginia Cancer Specialists PC, Fairfax
RecruitingPhase 1
Ages 18 and older · Men · Updated Nov 12, 2026 · NCT04221542Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- Potomac Urology, Woodbridge
Recruiting
Ages 18 and older · Men · Updated Nov 12, 2026 · NCT06511141The Vanguard Study: Testing a New Way to Screen for Cancer
- Sentara Martha Jefferson Hospital, Charlottesville
- Inova Schar Cancer Institute, Fairfax
- Inova Fair Oaks Hospital, Fairfax
- and 5 more
RecruitingHealthy volunteers welcome
Ages 45 to 75 · All sexes · Updated Nov 6, 2026 · NCT06995898WATER IV PCa (AS Sub-study)
- Potomac Urology, Alexandria
Recruiting
Ages 45 and older · Men · Updated Nov 6, 2026 · NCT07650448Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- Virginia Cancer Specialists, Fairfax
RecruitingPhase 2
Ages 18 and older · Men · Updated Nov 5, 2026 · NCT07745361Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Chesapeake Regional Medical Center, Chesapeake
- Augusta Health Center for Cancer and Blood Disorders, Fishersville
- Bon Secours Memorial Regional Medical Center, Mechanicsville
- and 7 more
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Nov 4, 2026 · NCT05334069Distance-Based Exercise to Preserve Function and Prevent Disability
- Bon Secours Memorial Regional Medical Center, Mechanicsville
- Bon Secours Saint Francis Medical Center, Midlothian
- Bon Secours Saint Mary's Hospital, Richmond
Recruiting
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07059884Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Bon Secours Memorial Regional Medical Center, Mechanicsville
- Bon Secours Saint Francis Medical Center, Midlothian
- Bon Secours Richmond Community Hospital, Richmond
- and 4 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT06632977Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- VCU Massey Comprehensive Cancer Center, Richmond
RecruitingPhase 3
Ages 18 and older · Men · Updated Nov 3, 2026 · NCT07200830Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Hematology Oncology Associates of Fredericksburg Inc, Fredericksburg
- VCU Massey Cancer Center at Stony Point, Richmond
- VCU Massey Comprehensive Cancer Center, Richmond
- and 1 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Nov 3, 2026 · NCT06931340Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Virginia Clinical Research, Norfolk
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Nov 3, 2026 · NCT06800313Autonomic and Renal Contributions to Hypertension With ADT
- Virginia Commonwealth University, Richmond
RecruitingPhase 4Healthy volunteers welcome
Ages 40 and older · Men · Updated Nov 2, 2026 · NCT07848828Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- NEXT Virginia, Fairfax
RecruitingPhase 1
Ages 18 and older · Men · Updated Oct 27, 2026 · NCT05997615Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Augusta Health Center for Cancer and Blood Disorders, Fishersville
- Bon Secours Memorial Regional Medical Center, Mechanicsville
- VCU Massey Cancer Center at Hanover Medical Park, Mechanicsville
- and 5 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 23, 2026 · NCT05946213A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 102, Fairfax
- Research Site 112, Fairfax
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 21, 2026 · NCT05914116A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- University of Virginia Health System ( Site 0054), Charlottesville
- Inova Schar Cancer Institute ( Site 0017), Fairfax
- Virginia Cancer Specialists (VCS) ( Site 8004), Fairfax
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 20, 2026 · NCT06136650A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- University of Virginia Cancer Center, Charlottesville
- Virginia Cancer Specialists PC, Leesburg
- Bon Secours Cancer Institute at Saint Francis, Midlothian
- and 1 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 20, 2026 · NCT07213674A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Norfolk
- Research Site, Roanoke
- Research Site, Virginia Beach
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 14, 2026 · NCT06952803This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Blue Ridge Cancer Care, Blacksburg
- University of Virginia Comprehensive Cancer Center, Charlottesville
- University of Virginia, Charlottesville
- and 5 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 14, 2026 · NCT07028853Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- Bon Secours Saint Francis Medical Center, Midlothian
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- VCU Massey Cancer Center at Stony Point, Richmond
- and 2 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 8, 2026 · NCT03678025FOG-001 in Locally Advanced or Metastatic Solid Tumors
- University of Virginia, Charlottesville
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 7, 2026 · NCT05919264The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Virginia Cancer Specialists, Fairfax
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Oct 2, 2026 · NCT04585750Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
- Hampton University Proton Therapy Institute, Hampton
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 29, 2026 · NCT01492972Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
- Virginia Urology Center, Richmond
Recruiting
Ages 18 and older · Men · Updated Sep 28, 2026 · NCT06496256Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Virginia Cancer Specialists, Fairfax
- Onco Hemato Asso of SW Virginia, Roanoke
RecruitingPhase 2/3
Ages 18 to 100 · Men · Updated Sep 22, 2026 · NCT06780670Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
- Virginia Oncology Associates - Hampton, Norfolk
RecruitingPhase 1
Ages 18 and older · Men · Updated Sep 15, 2026 · NCT07493512A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
- NEXT Oncology, Fairfax
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06440005A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
- University of Virginia Cancer Center, Charlottesville
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 3, 2026 · NCT07005154Prostate Active Surveillance Study
- Eastern Virginia Medical School, Norfolk
RecruitingObservational study
Ages 21 and older · Men · Updated Sep 2, 2026 · NCT00756665A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
- NEXT Oncology - Virginia, Fairfax
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Aug 20, 2026 · NCT06785636Water Vapor Ablation for Prostate Cancer: Long-Term Registry
- Urology of Virginia, Virginia Beach
RecruitingObservational study
All ages · Men · Updated Aug 18, 2026 · NCT07455058A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- University of Virginia Comprehensive Cancer Center, Charlottesville
RecruitingPhase 2
Ages 18 and older · Men · Updated Aug 17, 2026 · NCT06842498Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- University of Virginia Cancer Center, Charlottesville
- Bon Secours Memorial Regional Medical Center, Mechanicsville
- Bon Secours Saint Francis Medical Center, Midlothian
- and 3 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Jul 14, 2026 · NCT06592924Study of ORIC-944 in Patients With Metastatic Prostate Cancer
- Virginia Oncology Associates, Fairfax
- Virginia Cancer Specialists, Norfolk
RecruitingPhase 1
Ages 18 and older · Men · Updated Jul 9, 2026 · NCT05413421Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- Inova Schar Cancer Institute, Fairfax
Recruiting
Ages 18 and older · Men · Updated Jun 17, 2026 · NCT00969111HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)
- University of Virginia, Charlottesville
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT07441889A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor Symptoms in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer (Prostate 007)
- University of Virginia Health System, Charlottesville
Recruiting
Ages 18 and older · Men · Updated Jun 9, 2026 · NCT07535541Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- Onco Hemato Asso of SW Virginia, Roanoke
RecruitingPhase 4
Ages 18 to 100 · Men · Updated Jun 4, 2026 · NCT05803941A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer
- NEXT Oncology, Fairfax
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Jun 4, 2026 · NCT06609005From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.